Marc Lichtenfeld Blog | Talkmarkets | Page 1
Equities Analyst by Day/Ring Announcer by Night

Marc is the Chief Income Strategist for The Oxford Club and Wealthy Retirement, as well as Founder and Senior Editor of The Oxford Income Letter. He also contributes frequently to The Oxford Communiqué and Investment U.

Marc is Editor of VIP Trading ... more

All Contributions

Latest Posts
1 to 16 of 354 Posts
1 2 3 ... 23
JPM: Count On This Banking Giant
Let’s take a look at the bank’s numbers to see whether it can afford to hike the dividend once the Federal Reserve gives the green light.
How To Profit From The Crypto Craze
Everyone wants to know whether bitcoin can continue its impressive rise. It absolutely can go higher, but it can also go lower. So can other cryptocurrencies. Bitcoin isn’t the only fish in the sea.
SPH: This Small Cap’s 8% Yield Ain’t Right
The company’s free cash flow slipped last year to $177 million from $192 million. This year, it is forecast to decline another 7% to $164 million.
A 4.5% Yield Even More Reliable Than Its Network
Verizon has raised its dividend every year for 15 years straight. It has historically done so in the third quarter.
Cash In On Reefer Madness
After marijuana stocks ignited like a bowl of weed in a college fraternity house earlier in the year, the stock market harshed the buzz of investors in the sector. Marijuana stocks haven’t done much since February.
Why You Should Invest Now
Not everyone has decades to invest and build up their nest egg. But that’s why it’s so important to invest now and not wait for a better opportunity. Chances are you’re not going to be able to pull the trigger if one comes along.
SUN: Can This Double-Digit Yielder Keep Delivering?
Sunoco consistently raised the distribution every quarter until it hit $0.8255 per unit in November 2016, where it has remained since. It has never cut the distribution.
Will President Biden Sink The Stock Market?
President Biden has proposed trillions of dollars in stimulus spending and a hike in taxes on corporations and the wealthy. Anyone who is paying attention is expecting this to result in inflation.
Does Pfizer’s COVID-19 Vaccine Secure Its Dividend?
Even before the COVID-19 pandemic hit, Pfizer investors were likely drawn to the stock’s solid dividend and history of annual payout increases.
Why Phase 2 Trials Are Important To Investors (And Why I’m Enrolled In One)
The biotech sector tends to attract investors who are interested in exciting new medical advances and are drawn to big profits. There are lots of ways to invest in the sector.
The Secret To Successful Biotech Investing
As we advance in years, more people get sick and require more medicines for difficult-to-treat diseases. So if I could invest in only one sector for the next five or ten years, it would be biotech. But how do you choose which ones to invest in?
Downgrading Icahn’s 15% Yield
The company pays $2 per share quarterly. At the stock’s current price, that comes out to a 15% yield.
HH Have COVID-19 Vaccines Shifted The Pharma Pricing Debate?
Big Pharma and biotech are more or less recession-proof because a patient is generally not going to stop taking life-saving medicine just because the economy or the market is bad.
Why Gold Deserves A Place In Your Portfolio
Gold seems to make headlines every day now. If you don’t own any gold, should you buy some now? If you do already own some, should you buy more?
How To Be David To Wall Street’s Goliath
The longer you hold your Perpetual Dividend Raisers, the less performance you need out of the stocks – though companies that raise their dividends every year typically are growing earnings and cash flow and perform quite well.
NAT: A 12% Yield As Reliable As Your Crazy Friend
The Bermuda-based oil tanker company’s financial results are as consistent as a middle school orchestra. The main issue is that its free cash flow is all over the place.
1 to 16 of 354 Posts
1 2 3 ... 23